Literature DB >> 3384468

Renal nerves and the development of Dahl salt-sensitive hypertension.

J L Osborn1, R J Roman, J D Ewens.   

Abstract

Several experimental forms of hypertension require intact renal innervation for the development or maintenance (or both) of the elevated arterial pressure. We determined the relationships between urinary sodium and water excretion and arterial pressure in Dahl salt-sensitive rats (DS) with innervated (n = 6) and denervated (n = 7) kidneys after switching from a low to a high sodium diet. Arterial pressure significantly increased in both groups within 48 hours after they began to eat an 8% sodium chloride diet. This hypertension increased to 188 +/- 9 and 190 +/- 7 mm Hg, respectively, in rats with innervated and denervated kidneys after 12 days. Mean arterial pressures were not significantly different between groups on any day. The rise in arterial pressure of DS placed on a high sodium intake was associated with an elevation of urine flow rate and urinary sodium excretions in rats with either innervated or denervated kidneys. Urine flow rates and urinary sodium excretions were greater in denervated than in innervated rats on Days 4 through 7 after beginning the high sodium diet. This diuresis and natriuresis in rats with denervated kidneys were associated with greater water and sodium intakes on Days 4 to 7 of the high sodium diet when compared with rats with innervated kidneys. These results demonstrate that, following exposure to a high sodium intake, DS have increased arterial pressure within 24 hours. The development of this arterial hypertension is not dependent on intact renal innervation. In conscious DS, the renal innervation does participate in the regulation of urinary sodium excretion by promoting renal sodium and water reabsorption.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384468     DOI: 10.1161/01.hyp.11.6.523

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Renal nerves and leukocyte infiltration in the kidney during salt-sensitive hypertension.

Authors:  Ammar J Alsheikh; Hayley Lund; John Henry Dasinger; Justine M Abais-Battad; Daniel J Fehrenbach; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-05       Impact factor: 3.619

Review 2.  Role of the epithelial sodium channel in salt-sensitive hypertension.

Authors:  Yan Sun; Jia-ning Zhang; Dan Zhao; Qiu-shi Wang; Yu-chun Gu; He-ping Ma; Zhi-ren Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-05-30       Impact factor: 6.150

Review 3.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

4.  Renal denervation attenuates hypertension but not salt sensitivity in ETB receptor-deficient rats.

Authors:  Bryan K Becker; Amanda C Feagans; Daian Chen; Malgorzata Kasztan; Chunhua Jin; Joshua S Speed; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-12       Impact factor: 3.619

5.  Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

6.  Intracarotid hypertonic sodium chloride differentially modulates sympathetic nerve activity to the heart and kidney.

Authors:  Robert Frithiof; Tao Xing; Michael J McKinley; Clive N May; Rohit Ramchandra
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

7.  Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.

Authors:  Heitaro Watanabe; Yoshitaka Iwanaga; Yuki Miyaji; Hiromi Yamamoto; Shunichi Miyazaki
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.